These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23869361)

  • 1. Physicochemical, pharmacologic, and in vitro cellular effects of loading collagen membranes with zoledronic acid.
    Liao J; Meng Y; Zhai J; Wen C; Ten M; Tian A; Wang Y; Liang X
    Int J Oral Maxillofac Implants; 2013; 28(4):1027-36. PubMed ID: 23869361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the effects of zoledronic-acid-loaded collagen membrane on bone metabolism cells].
    Meng YH; Peng Y; Liu D; Chen Y; Wang H; Liang X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Feb; 46(2):107-11. PubMed ID: 21426781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation of zoledronic-acid-loaded collagen membrane].
    Meng YH; Liang X; Peng Y; Chen Y; Wang H; Huang D; Zang CC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):840-3, 853. PubMed ID: 21302454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs which inhibit osteoclast function suppress tumor growth through calcium reduction in bone.
    Li X; Liao J; Park SI; Koh AJ; Sadler WD; Pienta KJ; Rosol TJ; McCauley LK
    Bone; 2011 Jun; 48(6):1354-61. PubMed ID: 21419883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histomorphometric evaluation of the effects of zoledronic acid on mandibular distraction osteogenesis in rabbits.
    Pampu AA; Dolanmaz D; Tüz HH; Avunduk MC; Kişnişci RS
    J Oral Maxillofac Surg; 2008 May; 66(5):905-10. PubMed ID: 18423279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating.
    Greiner S; Kadow-Romacker A; Schmidmaier G; Wildemann B
    J Biomed Mater Res A; 2009 Oct; 91(1):288-95. PubMed ID: 18980195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties.
    Pozzi S; Vallet S; Mukherjee S; Cirstea D; Vaghela N; Santo L; Rosen E; Ikeda H; Okawa Y; Kiziltepe T; Schoonmaker J; Xie W; Hideshima T; Weller E; Bouxsein ML; Munshi NC; Anderson KC; Raje N
    Clin Cancer Res; 2009 Sep; 15(18):5829-39. PubMed ID: 19737962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts.
    Zara S; De Colli M; di Giacomo V; Zizzari VL; Di Nisio C; Di Tore U; Salini V; Gallorini M; Tetè S; Cataldi A
    Clin Oral Investig; 2015 Apr; 19(3):601-11. PubMed ID: 25055744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of β-tricalcium phosphate coated with zoledronic acid on human osteoblasts and human osteoclasts in vitro.
    Kadow-Romacker A; Greiner S; Schmidmaier G; Wildemann B
    J Biomater Appl; 2013 Jan; 27(5):577-85. PubMed ID: 21862509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts.
    Zafar S; Coates DE; Cullinan MP; Drummond BK; Milne T; Seymour GJ
    Clin Oral Investig; 2016 Nov; 20(8):2023-2035. PubMed ID: 26795621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis.
    Sims NA; Green JR; Glatt M; Schlict S; Martin TJ; Gillespie MT; Romas E
    Arthritis Rheum; 2004 Jul; 50(7):2338-46. PubMed ID: 15248235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis.
    Herrak P; Görtz B; Hayer S; Redlich K; Reiter E; Gasser J; Bergmeister H; Kollias G; Smolen JS; Schett G
    Arthritis Rheum; 2004 Jul; 50(7):2327-37. PubMed ID: 15248234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zoledronate promotes bone formation by blocking osteocyte-osteoblast communication during bone defect healing.
    Cui P; Liu H; Sun J; Amizuka N; Sun Q; Li M
    Histol Histopathol; 2018 Jan; 33(1):89-99. PubMed ID: 28345127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoblast response to titanium surfaces coated with strontium ranelate-loaded chitosan film.
    Tian A; Zhai JJ; Peng Y; Zhang L; Teng MH; Liao J; Sun X; Liang X
    Int J Oral Maxillofac Implants; 2014; 29(6):1446-53. PubMed ID: 25397808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doses effects of zoledronic acid on mineral apatite and collagen quality of newly-formed bone in the rat's calvaria defect.
    Olejnik C; Falgayrac G; During A; Cortet B; Penel G
    Bone; 2016 Aug; 89():32-39. PubMed ID: 27168397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexrazoxane shows cytoprotective effects in zoledronic acid-treated human cells in vitro and in the rabbit tibia model in vivo.
    Draenert GF; Huetzen DO; Kämmerer PW; Palarie V; Nacu V; Wagner W
    J Craniomaxillofac Surg; 2012 Dec; 40(8):e369-74. PubMed ID: 22429609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior administration of vitamin K2 improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization.
    Zhao B; Zhao W; Wang Y; Zhao Z; Zhao C; Wang S; Gao C
    PLoS One; 2018; 13(8):e0202269. PubMed ID: 30125322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
    Patntirapong S; Singhatanadgit W; Chanruangvanit C; Lavanrattanakul K; Satravaha Y
    J Oral Pathol Med; 2012 Oct; 41(9):713-20. PubMed ID: 22563819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of systemic zoledronic Acid administration on osseointegration of hydroxyapatite-coated and resorbable blast material surface implants in rabbit models.
    Yaman F; Ağaçayak S; Atilgan S; Benlidayi E; Ucan MC; Erol B; Kaya B; Gunay A; Guven S
    Int J Oral Maxillofac Implants; 2012; 27(6):1443-7. PubMed ID: 23189295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis.
    Verdrengh M; Carlsten H; Ohlsson C; Tarkowski A
    J Orthop Res; 2007 Mar; 25(3):304-10. PubMed ID: 17089391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.